When pharmacy leaders at The Johns Hopkins Hospital, in Baltimore, decided to produce their own IV syringe products, they went big—installing an 8-foot–high, 1,900-pound high-speed compounding robot.
Hospitals typically purchase IV syringes from 503B compounding facilities to get extended beyond-use dating (BUD) and medications in a ready-to-administer dosage form, said Matthew Broadwater, PharmD, MBA, BCPS, a clinical pharmacy manager of critical care and perioperative